GL
BLUE

GLG LLC’s bluebird bio BLUE Stock Holding History

GLG LLC’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4.27M Buy
+1,853
New +$3.76M 0.31% 90
2015
Q4 		– Sell
-5,708
Closed -$6.33M – 543
2015
Q3 		$6.33M Sell
5,708
-3,457
-38% -$6.3M 0.16% 156
2015
Q2 		$20M Buy
9,165
+5,510
+151% +$11.2M 0.43% 61
2015
Q1 		$5.72M Buy
3,655
+3,043
+497% +$4.01M 0.16% 165
2014
Q4 		$727K Buy
+612
New +$409K 0.02% 513

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

GLG LLC's BLUE Position: Q4 2017 in Review

GLG LLC opened a new position in bluebird bio (BLUE) in Q4 2017: 1,853 shares worth $4.27M. The stake represents 0.31% of the portfolio and ranks #90 among its holdings. This is a return to the name: GLG LLC previously reported a position in BLUE as recently as Q3 2015.

GLG LLC first reported a position in BLUE in Q4 2014 and has held it in 5 quarters since. The position peaked at $20M in Q2 2015. 296 funds tracked by Wall St. Rank hold BLUE as of Q4 2017.

  • GLG LLC held 1,853 shares of bluebird bio worth $4.27M as of Q4 2017.
  • bluebird bio was a new GLG LLC position in Q4 2017.
  • bluebird bio made up 0.31% of GLG LLC's portfolio in Q4 2017, its #90 holding.
  • GLG LLC first reported a position in bluebird bio in Q4 2014 and has held it in 5 quarters since.
  • GLG LLC's bluebird bio position peaked at $20M in Q2 2015.
  • 296 funds tracked by Wall St. Rank held bluebird bio as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.